According to Zoetis's latest financial reports the company's total assets are $14.28 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $14.28 B | -4.28% |
2022-12-31 | $14.92 B | 7.37% |
2021-12-31 | $13.90 B | 2.14% |
2020-12-31 | $13.60 B | 17.88% |
2019-12-31 | $11.54 B | 7.13% |
2018-12-31 | $10.77 B | 25.52% |
2017-12-31 | $8.58 B | 12.25% |
2016-12-31 | $7.64 B | -3.34% |
2015-12-31 | $7.91 B | 20.11% |
2014-12-31 | $6.58 B | 0.46% |
2013-12-31 | $6.55 B | 4.73% |
2012-12-31 | $6.26 B | 9.65% |
2011-12-31 | $5.71 B | 8.08% |
2010-12-31 | $5.28 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 1,485.48% | ๐บ๐ธ USA |
Eli Lilly LLY | $64.00 B | 348.04% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 878.69% | ๐ซ๐ท France |
Merck MRK | $106.67 B | 646.71% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $0.97 B | -93.19% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | N/A | N/A | ๐บ๐ธ USA |
Heska Corporation
HSKA | $0.59 B | -95.85% | ๐บ๐ธ USA |